ANAB- Anaptysbio, Inc.

Name: Anaptysbio, Inc. Insider Trading Data
Creator: U.S. Securities and Exchange Commission
License: https://www.sec.gov/privacy#accessibility

Anaptysbio, Inc. (ANAB) has 11 insiders with recent SEC Form 4 filings, including 0 buys and 25 sells. ANAB is classified in the Biotechnology industry within the Health Care sector.

Insider Ownership

Role	Insider	Shares	Value	30d
CEO	Faga Daniel	504.9K	$32.46M	-
Other	Lizzul Paul F.	42.1K	$2.71M	-
Dir	Schmid John P.	39.7K	$2.55M	-
CFO	Mulroy Dennis	21.9K	$1.40M	-
Other	Loumeau Eric J	12.8K	$825.2K	-

Activity

Buys and sells only

Transactions

10 filings

Date	Insider	Role	Type	Shares	Price	Value	Chg%	3M	12M
Mar 30, 2026	Schmid John P.80	Director	Sell	20,645	$56.11	$1,158,451.42	-16.6%	-	-
Mar 27, 2026	Faga Daniel61	President, CEO	Sell	17,679	$61.61	$1,089,198.74	-0.3%	-	-
Jan 15, 2026	Marquet Magda54	Director	Sale+OE	11,000	$48.23	$530,531.29	-33.8%	+51.4%	-
Jan 8, 2026	Lizzul Paul F.68	Chief Medical Officer	Sale+OE	3,650	$44.71	$163,191.50	-8.0%	+49.6%	-
Jan 8, 2026	Mulroy Dennis59	Chief Financial Officer	Sale+OE	2,515	$44.71	$112,445.65	-10.3%	+49.6%	-
Jan 8, 2026	Loumeau Eric J61	Chief Legal Officer	Sale+OE	2,210	$44.71	$98,809.10	-14.7%	+49.6%	-
Jan 8, 2026	Faga Daniel61	President, CEO	Sale+OE	14,281	$44.71	$638,503.51	-2.9%	+49.6%	-
Jan 7, 2026	Loumeau Eric J61	Chief Legal Officer	Sale+OE	9,639	$45.56	$439,199.76	-17.0%	+37.4%	-
Jan 7, 2026	Lizzul Paul F.68	Chief Medical Officer	Sale+OE	2,235	$45.11	$100,820.85	-5.7%	+37.4%	-
Jan 7, 2026	Faga Daniel61	President, CEO	Sale+OE	9,202	$45.11	$415,102.22	-1.9%	+37.4%	-

Page 1Next →

Insider	Role	Shares	Value	Buys	Sells

Date	Ticker	Insider	Role	Type	Shares	Price	Value	Chg%	SEC